Serum thymus and activation‐regulated chemokine (TARC/CCL17) may be useful to predict the disease activity in patients with bullous pemphigoid-Reference-Cited by-同舟云学术

Serum thymus and activation‐regulated chemokine (TARC/CCL17) may be useful to predict the disease activity in patients with bullous pemphigoid

Published:2020-09 Issue:2 Volume:35 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Suzuki M.¹²,Yamaguchi Y.¹^ORCID,Nakamura K.²,Kanaoka M.¹,Matsukura S.²,Takahashi K.¹,Takahashi Y.³,Kambara T.²,Aihara M.¹

Affiliation:

1. Department of Environmental Immuno‐Dermatology Yokohama City University Graduate School of Medicine Yokohama Japan

2. Department of Dermatology Yokohama City University Medical Centre Yokohama Japan

3. NHO Shizuoka Institute of Epilepsy and Neurological Disorders Shizuoka Japan

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.16851

Reference8 articles.

1. Relapse of bullous pemphigoid: an update on this stubborn clinical problem;Wang Y;Ann Med,2018

2. Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study;Bernard P;Arch Dermatol,2009

3. Clinical and immunologic factors associated with bullous pemphigoid relapse during the first year of treatment: a multicenter, prospective study;Fichel F;JAMA,2014

4. Pemphigud and pemphigoid: a review of advances made since 1964;Lever WF;J Am Acad Dermatol,1979

5. Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts;Murrell DF;J Am Acad Dermatol,2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-cell transcriptomics analysis of bullous pemphigoid unveils immune-stromal crosstalk in type 2 inflammatory disease;Nature Communications;2024-07-15

2. Immunobullous Diseases;Rook's Textbook of Dermatology;2024-03-19

3. TARC/CCL17 reflects the severity of pemphigus (pemphigus vulgaris and pemphigus foliaceus) at the initial presentation;JEADV Clinical Practice;2024-03-11

4. Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types;Frontiers in Immunology;2023-07-27

5. A case of bullous pemphigoid with correlation to serum levels of anti‐BP180‐NC16a antibodies and thymus and activation‐regulated chemokine;Journal of Cutaneous Immunology and Allergy;2023-06-08